Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Whiteley is an Australian family-owned healthcare products company focused on infection prevention, medical device reprocessing, sterilants, disinfectants, and professional hygiene solutions. The company manufactures TGA-licensed therapeutic goods and supplies hospitals, endoscopy units, sterilisation departments, aged care, dental, and other healthcare settings. Whiteley emphasizes clinically driven innovation, including biofilm-removal technologies such as Surfex, and has expanded its manufacturing footprint with a human therapeutics plant in Tomago, New South Wales. Its business is primarily commercial rather than drug-development oriented, with products marketed across Australia, New Zealand, the United States, and other international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Whiteley.